On April 12, 2026, several South Korean companies in the beauty, medical device, and pharmaceutical sectors saw significant stock price increases following the release of strong first-quarter earnings. **d'Alba Global (Beauty Brand)** - Announced preliminary consolidated Q1 2026 results at 10:00 AM KST. - Revenue: KRW 171.24 billion, up 50.5% YoY. - Operating profit: KRW 45.09 billion, up 50.0% YoY. - Net profit: KRW 36.34 billion, up 46.8% YoY (record quarterly high). - Overseas revenue reached KRW 117.7 billion, up 85% YoY, driving overall growth. - Stock price jumped from KRW 217,000 (09:59) to KRW 224,500 (10:00) upon announcement, peaking at KRW 274,500 (+20%) by 10:09. Closed at KRW 247,000 (+13.04%). - d'Alba Global, founded in 2016, operates the premium vegan beauty brand 'd'Alba' and is known for its 'White Truffle First Spray Serum'. Analysts expect continued growth in North America and Europe.
**Rayence (Medical Imaging)** - Announced preliminary consolidated Q1 2026 results at 1:58 PM KST. - Revenue: KRW 36.75 billion, up 34.9% YoY. - Operating profit: KRW 3.58 billion; net profit: KRW 5.86 billion (return to profitability). - Rayence is the only South Korean company with a full lineup of X-ray detectors for dental, medical, veterinary, and industrial use. - Stock price rose from KRW 5,880 (13:57) to KRW 6,590 (13:58), peaking at KRW 7,000 (+18%) by 14:01. Closed at KRW 6,320 (+5.33%). **CTC Bio (Animal & Human Pharmaceuticals)** - Filed Q1 2026 quarterly report at 10:42 AM KST. - Revenue: KRW 34.4 billion, up 16.9% YoY.
- Operating profit: KRW 4.6 billion, up 414% YoY. - Net profit: KRW 3.5 billion, up 451% YoY. - Growth attributed to expanded overseas exports and higher-margin product sales. - Stock price moved from KRW 3,480 (10:41) to KRW 3,750 (10:42), later reaching KRW 4,500 (near daily limit). Closed at KRW 4,200 (+17.81%). - CTC Bio has been restructuring since last year, focusing on cost efficiency, portfolio optimization, and high-margin products. **Kolmar BNH (Health Functional Foods & Cosmetics Ingredients)** - Announced preliminary consolidated Q1 2026 results at 9:34 AM KST. - Revenue: KRW 136.89 billion, up 0.12% YoY. - Operating profit: KRW 10.33 billion, up 188.55% YoY.
- Net profit: KRW 22.36 billion, up 1,450.97% YoY (return to profitability). - Kolmar BNH is a joint R&D venture between Kolmar Korea and the Korea Atomic Energy Research Institute, specializing in natural material-based ingredients for health foods and cosmetics. - Stock price rose from KRW 11,150 (09:33) to KRW 11,620 (09:34), peaking at KRW 12,500 (+12.6%) shortly after 10:00. Closed at KRW 12,080 (+8.83%). **Outlook** - d'Alba Global's future stock performance will depend on sustained overseas growth and product diversification. - Rayence's key challenge is maintaining stable profitability after returning to the black. - CTC Bio plans to continue expanding market share abroad, focusing on high-value products, and improving production efficiency. - Kolmar BNH's growth will rely on developing new materials aligned with market trends and expanding globally.
Source: Read the original report | Published: April 12, 2026